{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:31:56Z","timestamp":1793680316622,"version":"4.5.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Washington University School of Medicine Summer Research Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13181-021-00858-z","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T01:31:21Z","timestamp":1632447081000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Methadone vs. Buprenorphine for In-Hospital Initiation: Which Is Better for Outpatient Care Retention in Patients with Opioid Use Disorder?"],"prefix":"10.1007","volume":"18","author":[{"given":"Skyler H.","family":"Kessler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0810-8011","authenticated-orcid":false,"given":"David B.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"key":"858_CR1","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 1999\u20132018. Hyattsville, MD: National Center for Health Statistics; 2020. Report No.: 356."},{"key":"858_CR2","unstructured":"Kochanek KD, Murphy SL, Xu J, Arias E. Deaths: final data for 2017. Hyattsville, MD: National Center for Health Statistics; Report No.: vol 68 no 9."},{"key":"858_CR3","unstructured":"Jonaki Bose, Hedden SL, Lipari RN, Park-Lee E. Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration (SAMHSA); 2018."},{"key":"858_CR4","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","volume":"313","author":"G D\u2019Onofrio","year":"2015","unstructured":"D\u2019Onofrio G, O\u2019Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, et al. Emergency department\u2013initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313:1636.","journal-title":"JAMA"},{"key":"858_CR5","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ajem.2019.02.025","volume":"37","author":"M Lowenstein","year":"2019","unstructured":"Lowenstein M, Kilaru A, Perrone J, Hemmons J, Abdel-Rahman D, Meisel ZF, et al. Barriers and facilitators for emergency department initiation of buprenorphine: a physician survey. Am J Emerg Med. 2019;37:1787\u201390.","journal-title":"Am J Emerg Med"},{"key":"858_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, Kariisa M, Seth P, Smith H, Davis NL. Drug and opioid-involved overdose deaths \u2014 United States, 2017\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69:290\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"858_CR7","doi-asserted-by":"publisher","first-page":"e195388","DOI":"10.1001\/jamanetworkopen.2019.5388","volume":"2","author":"JS Guadamuz","year":"2019","unstructured":"Guadamuz JS, Alexander GC, Chaudhri T, Trotzky-Sirr R, Qato DM. Availability and cost of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 2017. JAMA Netw Open. 2019;2:e195388.","journal-title":"JAMA Netw Open"},{"key":"858_CR8","unstructured":"Missouri Opioids Factsheet [Internet]. Missouri Department of Health and Senior Services, Bureau of Healthcare Analysis and Data Dissemination. 2020 [cited 2020 Feb 7]. Available from:\u00a0https:\/\/health.mo.gov\/data\/opioids.\u00a0Accessed\u00a07 Feb\u00a02020"},{"key":"858_CR9","unstructured":"Missouri Opioid Overdose and Bloodborne Infection Vulnerability Assessments [Internet]. Missouri Department of Health and Senior Services, Bureau of Reportable Disease Informatics. 2020 [cited 2020 Feb 7]. Available from:\u00a0http:\/\/health.mo.gov\/data\/opioids\/assessments.php.\u00a0Accessed 7 Feb 2020"},{"key":"858_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","volume":"75","author":"SG Weiner","year":"2020","unstructured":"Weiner SG, Baker O, Bernson D, Schuur JD. One-year mortality of patients after emergency department treatment for nonfatal opioid overdose. Ann Emerg Med. 2020;75:13\u20137.","journal-title":"Ann Emerg Med"},{"key":"858_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0376-8716(98)00097-0","volume":"52","author":"DA Zanis","year":"1998","unstructured":"Zanis DA, Woody GE. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend. 1998;52:257\u201360.","journal-title":"Drug Alcohol Depend"},{"key":"858_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","volume":"40","author":"RE Johnson","year":"1995","unstructured":"Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend. 1995;40:17\u201325.","journal-title":"Drug Alcohol Depend"},{"key":"858_CR13","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Drugs and Alcohol Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2014 [cited 2020 Jun 9]; Available from:\u00a0http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/14651858.CD002207.pub. Accessed 9 Jun 2020","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"858_CR14","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3:e1920622.","journal-title":"JAMA Netw Open"},{"key":"858_CR15","doi-asserted-by":"crossref","unstructured":"Krawczyk N, Mojtabai R, Stuart EA, Fingerhood M, Agus D, Lyons BC, et al. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services. Addiction. 2020;115(9):1683\u20131694.","DOI":"10.1111\/add.14991"},{"key":"858_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/08897077.2013.819828","volume":"35","author":"MI Fingerhood","year":"2014","unstructured":"Fingerhood MI, King VL, Brooner RK, Rastegar DA. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment. Subst Abus. 2014;35:122\u20136.","journal-title":"Subst Abus"},{"key":"858_CR17","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","volume":"104","author":"J Bell","year":"2009","unstructured":"Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009;104:1193\u2013200.","journal-title":"Addiction"},{"key":"858_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/add.13238","volume":"111","author":"Y Hser","year":"2016","unstructured":"Hser Y, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, et al. Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial. Addiction. 2016;111:695\u2013705.","journal-title":"Addiction"},{"key":"858_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","volume":"79","author":"P Trowbridge","year":"2017","unstructured":"Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, et al. Addiction consultation services \u2013 linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1\u20135.","journal-title":"J Subst Abuse Treat"},{"key":"858_CR20","doi-asserted-by":"publisher","first-page":"108146","DOI":"10.1016\/j.jsat.2020.108146","volume":"119","author":"K Cioe","year":"2020","unstructured":"Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder. J Subst Abuse Treat. 2020;119:108146.","journal-title":"J Subst Abuse Treat"},{"key":"858_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.amjmed.2015.09.024","volume":"129","author":"ES Rosenthal","year":"2016","unstructured":"Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016;129:481\u20135.","journal-title":"Am J Med"},{"key":"858_CR22","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174:1369.","journal-title":"JAMA Intern Med"},{"key":"858_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11606-010-1311-3","volume":"25","author":"CW Shanahan","year":"2010","unstructured":"Shanahan CW, Beers D, Alford DP, Brigandi E, Samet JH. A transitional opioid program to engage hospitalized drug users. J Gen Intern Med. 2010;25:803\u20138.","journal-title":"J Gen Intern Med"},{"key":"858_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.annemergmed.2018.11.032","volume":"73","author":"AA Herring","year":"2019","unstructured":"Herring AA, Perrone J, Nelson LS. Managing opioid withdrawal in the emergency department with buprenorphine. Ann Emerg Med. 2019;73:481\u20137.","journal-title":"Ann Emerg Med"},{"key":"858_CR25","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/cid\/ciy924","volume":"68","author":"LR Marks","year":"2019","unstructured":"Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis. 2019;68:1935\u20137.","journal-title":"Clin Infect Dis"},{"key":"858_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.annemergmed.2019.08.420","volume":"75","author":"FJ Edwards","year":"2020","unstructured":"Edwards FJ, Wicelinski R, Gallagher N, McKinzie A, White R, Domingos A. Treating opioid withdrawal with buprenorphine in a community hospital emergency department: an outreach program. Ann Emerg Med. 2020;75:49\u201356.","journal-title":"Ann Emerg Med"},{"key":"858_CR27","unstructured":"Committee on Medication-Assisted Treatment for Opioid Use Disorder, Board on Health Sciences Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives [Internet]. Leshner AI, Mancher M, editors. Washington, D.C.: National Academies Press; 2019 [cited 2020 Jun 9]. p. 25310. Available from: https:\/\/www.nap.edu\/catalog\/25310"},{"key":"858_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamapsychiatry.2018.3685","volume":"76","author":"K Fiscella","year":"2019","unstructured":"Fiscella K, Wakeman SE, Beletsky L. Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X Waiver. JAMA Psychiat. 2019;76:229.","journal-title":"JAMA Psychiat"},{"key":"858_CR29","unstructured":"Tonko P. Mainstreaming Addiction Treatment Act of 2019. H.R. 2482 May, 2019."},{"key":"858_CR30","unstructured":"Ruiz R. Easy Medication Access and Treatment (Easy MAT) for Opioid Addiction Act. H.R. 2281 Dec, 2020."}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-021-00858-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-021-00858-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-021-00858-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T16:32:46Z","timestamp":1642091566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-021-00858-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["858"],"URL":"https:\/\/doi.org\/10.1007\/s13181-021-00858-z","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}